Uncovering Institutional Buying In Apellis Pharmaceuticals Inc (NASDAQ: APLS)
Currently, there are 124.50M common shares owned by the public and among those 104.48M shares have been available to trade. The company’s stock has a 5-day price change of -4.55% and -30.60% over the past three months. APLS shares are trading -28.93% year to date (YTD), with the 12-month market performance down to -61.42% lower. […]
Are Analysts Expecting A Better 2020 For Apellis Pharmaceuticals Inc (APLS)?
Apellis Pharmaceuticals Inc (APLS) concluded trading on Thursday at a closing price of $68.12, with 2.62 million shares of worth about $178.14 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 181.84% during that period and on Thursday the price saw a gain of […]
